Who Paid My Doc
Jordan Day
Podiatrist, Foot & Ankle Surgery Lovington, NM Doctor of Podiatric Medicine
NPI 1265783997 CMS profile 193694
1600 N Main Ave, Lovington, NM 88260
General payments
$953
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Jordan Day of Lovington, NM is reported in the CMS Open Payments database as having received $953 across 19 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 30th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $34 | 2 | |
| 2024 | General | $52 | 3 | |
| 2023 | General | $730 | 5 | |
| 2022 | General | $21 | 2 | |
| 2021 | General | $51 | 3 | |
| 2020 | General | $48 | 3 | |
| 2019 | General | $17 | 1 |
Beside peers
- Jordan Day
- Podiatrist, Foot & Ankle Surgery median
- Middle half of Podiatrist, Foot & Ankle Surgery
- National median
In program year 2025, general payments to Jordan Day were reported at $34. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.
Show as a table
| Year | Jordan Day | Podiatrist, Foot & Ankle Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $17 | $389 | $118–$1,406 | $163 |
| 2020 | $48 | $191 | $62–$691 | $114 |
| 2021 | $51 | $329 | $104–$1,341 | $132 |
| 2022 | $21 | $419 | $125–$1,611 | $149 |
| 2023 | $730 | $377 | $128–$1,164 | $160 |
| 2024 | $52 | $394 | $134–$1,168 | $164 |
| 2025 | $34 | $424 | $139–$1,306 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 5 drugsPart D claims
98
Drug cost
$410
Branded share of claims
24.5%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Cephalexin | Generic | 40 | $134 | |
| Naproxen | Generic | 19 | $78 | |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | Brand | 12 | $72 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 12 | $65 | |
| Triamcinolone Acetonide | Generic | 15 | $62 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.
Records
19 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Podiatrist, Foot & Ankle Surgery in New Mexico
Joshua Wolfe
Podiatrist, Foot & Ankle Surgery · Las Cruces, NM
Adam Gough
Podiatrist, Foot & Ankle Surgery · Silver City, NM
Ruben Nunez
Podiatrist, Foot & Ankle Surgery · Las Vegas, NM
Alexander Ramirez
Podiatrist, Foot & Ankle Surgery · Las Vegas, NM
Harsh Amin
Podiatrist, Foot & Ankle Surgery · Las Vegas, NM
Stephanie Gonzalez
Podiatrist, Foot & Ankle Surgery · Las Cruces, NM
Related records
Podiatrist, Foot & Ankle Surgery in New Mexico
Practitioners in the same specialty and state, ranked by reported value.
All Podiatrist, Foot & Ankle Surgery
Everyone recorded under this specialty, nationwide.
Doctors in New Mexico
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.